Curiel DT - Search Results

1

Use of a tissue-specific promoter for targeted expression of the herpes simplex virus thymidine kinase gene in cervical carcinoma cells.

Robertson MW 3rd, Wang M, Siegal GP, Rosenfeld M, Ashford RS 2nd, Alvarez RD, Garver RI, Curiel DT. Robertson MW 3rd, et al. Among authors: curiel dt. Cancer Gene Ther. 1998 Sep-Oct;5(5):331-6. Cancer Gene Ther. 1998. PMID: 9824053

2

Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody.

Deshane J, Cabrera G, Grim JE, Siegal GP, Pike J, Alvarez RD, Curiel DT. Deshane J, et al. Among authors: curiel dt. Gynecol Oncol. 1995 Oct;59(1):8-14. doi: 10.1006/gyno.1995.1260. Gynecol Oncol. 1995. PMID: 7557620

3

Strategy for achieving selective killing of carcinomas.

Garver RI Jr, Goldsmith KT, Rodu B, Hu PC, Sorscher EJ, Curiel DT. Garver RI Jr, et al. Among authors: curiel dt. Gene Ther. 1994 Jan;1(1):46-50. Gene Ther. 1994. PMID: 7584059

4

Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway.

Michael SI, Curiel DT. Michael SI, et al. Among authors: curiel dt. Gene Ther. 1994 Jul;1(4):223-32. Gene Ther. 1994. PMID: 7584085 Review.

5

Receptor-mediated gene delivery employing lectin-binding specificity.

Batra RK, Wang-Johanning F, Wagner E, Garver RI Jr, Curiel DT. Batra RK, et al. Among authors: curiel dt. Gene Ther. 1994 Jul;1(4):255-60. Gene Ther. 1994. PMID: 7584089

6

Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines.

Deshane J, Loechel F, Conry RM, Siegal GP, King CR, Curiel DT. Deshane J, et al. Among authors: curiel dt. Gene Ther. 1994 Sep;1(5):332-7. Gene Ther. 1994. PMID: 7584099

7

A carcinoembryonic antigen polynucleotide vaccine for human clinical use.

Conry RM, LoBuglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Pike J, Curiel DT. Conry RM, et al. Among authors: curiel dt. Cancer Gene Ther. 1995 Mar;2(1):33-8. Cancer Gene Ther. 1995. PMID: 7621253 Clinical Trial.

8

Recombinant adenovirus-mediated gene transfer to genitourinary epithelium in vitro and in vivo.

Bass C, Cabrera G, Elgavish A, Robert B, Siegal GP, Anderson SC, Maneval DC, Curiel DT. Bass C, et al. Among authors: curiel dt. Cancer Gene Ther. 1995 Jun;2(2):97-104. Cancer Gene Ther. 1995. PMID: 7621262

9

Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors.

Lu D, Benjamin R, Kim M, Conry RM, Curiel DT. Lu D, et al. Among authors: curiel dt. Cancer Gene Ther. 1994 Dec;1(4):245-52. Cancer Gene Ther. 1994. PMID: 7627814

10

A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.

Conry RM, LoBuglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Curiel DT. Conry RM, et al. Among authors: curiel dt. Gene Ther. 1995 Jan;2(1):59-65. Gene Ther. 1995. PMID: 7712333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters